ZURICH, Sept 19 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Monday:
ABB ABBN.S
Swiss engineering group ABB has decided to keep its Power
Grids division, which was put under review last year, weekly
SonntagsZeitung said on Sunday citing a source at the company's
headquarters. urn:newsml:reuters.com:*:nL8N1BU07E
ABB's board will discuss the future of its Power Grids
division next week as investors ramp up pressure on the
technology group to spin off the $11.6 billion business. The
board will meet at an undisclosed location in Switzerland on
Tuesday, two sources close to the matter told Reuters on Friday.
urn:newsml:reuters.com:*:nL8N1BS35D
For more click ABBN.S
BANKS
Consolidation at the Swiss banking sector will continue and
the number of banks decrease, the head of the Swiss Bankers
Association told Le Temps paper.
Swiss lenders, being confronted with falling margins and
higher costs due to increasing regulation, digitalisation and
negative interest rates, need to further adjust their
structures, Helmut Scheidt said.
For more click BANK
LAFARGEHOLCIM LHN.S
LafargeHolcim is considering withdrawing from several
markets as part of its efforts to make last year's mega-merger a
success, Chairman Beat Hess told weekly Sonntagszeitung. "We
will be present in less countries for sure," Hess was quoted as
saying. The sale of operations in several countries was an
option, he said. urn:newsml:reuters.com:*:nL8N1BU06G
For more click LHN.S
NOVARTIS NOVN.S
The Swiss drugmaker's investigational multiple sclerosis
drug cut the risk of disability progression in patients with a
tough-to-treat form of the disease versus a placebo, the Swiss
company said on Saturday, citing a new analysis of a late-stage
trial. L8N1BS3NH
About 40 percent of chronic migraine sufferers taking an
experimental drug developed by Novartis and Amgen saw the number
of days they suffered a migraine cut by at least half, beating
the placebo in the trial. urn:newsml:reuters.com:*:nL8N1BS358
For more click NOVN.S
COMPANY STATEMENTS CPR-CH
* Syngenta SYNN.S said it has agreed the 120 million Swiss
franc expansion of its production site in Kaisten, Switzerland,
creating 20 new jobs SYNN.S
* New Value NEWN.S said it will receive a share of the
liability payment made by the company's former directors and
auditor to an investor following a settlement between the
parties. NEWN.S
ECONOMY M-CH
(Reporting by Zurich newsroom)
((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit:
https://emea1.views.cp.extranet.thomsonreuters.biz/Explorer/NEWSxTOPNEWS.aspx?group=SP_GROUP_001&page=SP_PAGE_001&pageName=FrontPage
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German................ .SDE
All SMI constituent stocks............................ 0#.SSMI
News on major Swiss stock price moves.................. CH-HOT
FTSE Eurotop 300 index................................ .FTEU3
DJ STOXX index........................................ .STOXX
Top 10 STOXX sectors............................. .PGL.STOXXS
Top 10 EUROSTOXX sectors........................ .PGL.STOXXES
Top 10 Eurotop 300 sectors....................... .PGL.FTEU3S
Top 25 European pct gainers... .PG.PEUR , losers... .PL.PEUR
Swiss mid-cap index .SSMI SMI futures 0#SMI:
Swiss all-share index .SSHI Market statistics CH/STATS1
Swiss market digest .AD.S Sector overview CH/SECTOR1
All Swiss news CH Swiss research news CH-RCH
All equity news E
INTERNET ADDRESSES:
Swiss Exchange www.swx.ch/
Eurex www.eurexchange.com
STOXX Ltd www.stoxx.com
SPEED GUIDES: VX/EQUITY EQUITY EQUITY/NEWS1 EUR/EQUITY
SWITZERLAND REUTERS ))
Keywords: MARKETS SWISS STOCKS/